Table 2.
ACQ, FEV1, FeNO, blood and sputum eosinophils 4 weeks after exacerbation.
| Exacerbation | 4 weeks follow-up | Delta-values | p-valuea | |
|---|---|---|---|---|
| ACQ | 3.3 (±1.47) | 1.5 (±1.26) | −1.80 (±1.32) | 0.0001 |
| FEV1 -Percentage of predicted | 68.3 (±23.5) | 78.6 (±21.3) | 10.3 (±14.4) | 0.015 |
| FeNO (ppb) | 42.2 (±23.6) | 31.5 (±29.3) | −10.7 (±35.83) | 0.27 |
| Blood eosinophils (x10ˆ/L) | 0.3 (±0.4) | 0.4 (±0.2) | 0.01 (±0.35) | 0.91 |
| Sputum Eosinophils (%) | 10.9 (±13.3) | 14.4 (±26.9) | 3.52 (±16.6) | 0.52 |
ACQ: asthma control questionnaire, FeNO: fractional expiratory nitric oxide, ppb: parts per billion.
a
Pairwise t-test of exacerbation versus 4 weeks follow-up.